Trial intelligence / Profile preview

Continuous IV Pantoprazole for Severe Erosive Esophagitis

NCT00133770Phase 4Completed

Sponsor
Emory University
Start
Jul 2004
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of pantoprazole in erosive esophagitis (EE) (2 arms), sponsored by Emory University. Primary endpoint: Percentage of patients healed from severe esophagitis at 7 days. Started Jul 2004; status: completed.

02

Drugs

pantoprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT00133770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00133770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call